info@uvaxbio.com | CONTACT US

About Us
Technologies
News
Publications
Investors

Archives for June 2019

Introduction To Ufovax & It’s Technology & Products (In Chinese)

June 5, 2019

Archives

March 2021 (2)
December 2020 (1)
September 2020 (2)
August 2020 (2)
July 2020 (1)
April 2020 (2)
March 2020 (1)
February 2020 (1)
June 2019 (1)
February 2019 (1)
November 2018 (3)
March 2018 (1)

Recent Posts

Reshaping The Vaccine Manufacturing Paradigm
Single-component, self-assembling, protein nanoparticles presenting the receptor binding domain and stabilized spike as SARS-CoV-2 vaccine candidates
Ufovax Extends Its Intellectual Property Portfolio to Include a Patent Covering the Design of an Optimized Antigen For COVID-19
Ufovax Announces Its Self-Assembling NanoParticles as the Next-Generation Vaccine Solution for COVID-19
Self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation COVID-19 vaccines

Uvax Bio

3801 Kennett Pike
Ste. A101, #4482
Wilmington, DE
19807-9998
info@uvaxbio.com

The Company
The Management
The Scientific Advisory Board
News
Investors
Contact Us

The 1c-SApNP Platform Technology
Coronavirus Vaccine
HIV Vaccine
HCV Vaccine

RSV/hMPV Vaccines
Ebola Vaccine
Malaria Vaccine
Tuberculosis Vaccine

© Uvax Bio 2021 | Created by TinyFrog Technologies